Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-24

Clinical Trial Update: A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab, [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Anavip with CroFab for rattlesnake envenomation; results completed and posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anavip (F(ab')2 antivenom)
  • Crotalidae polyvalent immune Fab (Crotalidae polyvalent immune Fab (ovine))

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Snake Bite, Blood Coagulation Disorders | Phase 2 | Status: COMPLETED | Results posted: 2009-03-24